Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC

Recruiting

Phase 2

PF-08634404Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC

Sponsor:

Pfizer

Code:

NCT07489066

Conditions

Carcinoma

Non-Small-Cell Lung

Lung Cancer (NSCLC)

Lung Neoplasms

Carcinoma, Non-Small-Cell Lung (NSCLC)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

PF-08634404

Chemotherapy Regimen 1

Chemotherapy Regimen 2

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-06-20. This information was provided to ClinicalTrials.gov by Pfizer on 2026-06-08.